417 is a clinical research site located in Lexington, Kentucky, United States.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
417 has participated in 2 clinical trials.
Therapeutic areas: Early Stage Parkinson's Disease, Early Stage Parkinson Disease.
Sponsors: Solvay Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
417 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
417 has 2 clinical trials on record. Their work covers Early Stage Parkinson's Disease, Early Stage Parkinson Disease.
417 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.